Axsome Therapeutics, Inc. - Common Stock (AXSM)

CUSIP: 05464T104

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / Common Stock
Shares outstanding
48,932,355
Total 13F shares
38,597,370
Share change
+300,290
Total reported value
$3,071,777,083
Put/Call ratio
55%
Price per share
$79.59
Number of holders
242
Value change
+$30,855,225
Number of buys
104
Number of sells
110

Security key

05464T104

Report period

Q4 2023

Institutions

242

Top holders

10

Top shareholders of AXSM - Axsome Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
RTW INVESTMENTS, LP
13F
Company
9.2%
4,489,596
$313,777,864 30 Sep 2023
13F
VANGUARD GROUP INC
13F
Company
7.6%
3,729,126
$260,628,617 30 Sep 2023
13F
BlackRock Finance, Inc.
13F
Company
6%
2,934,490
$205,091,507 30 Sep 2023
13F
Fairmount Funds Management LLC
13F
Company
4.8%
2,341,238
$163,629,124 30 Sep 2023
13F
BVF INC/IL
13F
Company
4.4%
2,131,100
$148,942,579 30 Sep 2023
13F
FMR LLC
13F
Company
3.8%
1,858,556
$129,894,497 30 Sep 2023
13F
CITADEL ADVISORS LLC
13F
Company
2.6%
1,295,624
$90,551,161 30 Sep 2023
13F
Deep Track Capital, LP
13F
Company
2.3%
1,140,745
$79,726,668 30 Sep 2023
13F
RA CAPITAL MANAGEMENT, L.P.
13F
Company
2%
1,000,000
$69,890,000 30 Sep 2023
13F
STATE STREET CORP
13F
Company
1.8%
867,647
$60,639,849 30 Sep 2023
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.6%
778,495
$54,416,051 30 Sep 2023
13F
ALETHEA CAPITAL MANAGEMENT, LLC
13F
Company
1.6%
758,794
$53,032,113 30 Sep 2023
13F
Pictet Asset Management Holding SA
13F
Company
1.3%
646,429
$45,178,923 30 Sep 2023
13F
Bellevue Group AG
13F
Company
1.3%
631,487
$44,134,626 30 Sep 2023
13F
Jefferies Financial Group Inc.
13F
Company
1.1%
553,195
$38,662,799 30 Sep 2023
13F
Point72 Asset Management, L.P.
13F
Company
1.1%
531,937
$37,177,077 30 Sep 2023
13F
PFM Health Sciences, LP
13F
Company
1.1%
523,210
$36,567,147 30 Sep 2023
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
1%
503,042
$35,157,605 30 Sep 2023
13F
PERCEPTIVE ADVISORS LLC
13F
Company
0.98%
481,649
$33,662,449 30 Sep 2023
13F
Woodline Partners LP
13F
Company
0.92%
452,107
$31,597,758 30 Sep 2023
13F
Boxer Capital, LLC
13F
Company
0.82%
400,000
$27,956,000 30 Sep 2023
13F
Nicholas Investment Partners, LP
13F
Company
0.81%
394,980
$27,605,152 30 Sep 2023
13F
Hood River Capital Management LLC
13F
Company
0.78%
383,276
$26,787,160 30 Sep 2023
13F
NORTHERN TRUST CORP
13F
Company
0.71%
349,057
$24,395,594 30 Sep 2023
13F
EVENTIDE ASSET MANAGEMENT, LLC
13F
Company
0.71%
346,712
$24,231,702 30 Sep 2023
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
0.66%
325,000
$22,714,250 30 Sep 2023
13F
TANG CAPITAL MANAGEMENT LLC
13F
Company
0.65%
320,000
$22,364,800 30 Sep 2023
13F
MORGAN STANLEY
13F
Company
0.61%
298,421
$20,856,645 30 Sep 2023
13F
Avidity Partners Management LP
13F
Company
0.61%
296,800
$20,743,352 30 Sep 2023
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.59%
289,871
$20,259,084 30 Sep 2023
13F
DRIEHAUS CAPITAL MANAGEMENT LLC
13F
Company
0.51%
248,889
$17,394,852 30 Sep 2023
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
0.49%
237,554
$16,602,649 30 Sep 2023
13F
Soleus Capital Management, L.P.
13F
Company
0.49%
237,500
$16,598,875 30 Sep 2023
13F
Nuveen Asset Management, LLC
13F
Company
0.44%
216,557
$15,135,169 30 Sep 2023
13F
NORGES BANK
13F
Company
0.43%
210,222
$14,692,416 30 Sep 2023
13F
JPMORGAN CHASE & CO
13F
Company
0.35%
172,456
$12,052,950 30 Sep 2023
13F
Bank of New York Mellon Corp
13F
Company
0.34%
168,006
$11,741,937 30 Sep 2023
13F
FRONTIER CAPITAL MANAGEMENT CO LLC
13F
Company
0.33%
160,676
$11,229,646 30 Sep 2023
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.33%
159,249
$11,129,913 30 Sep 2023
13F
HSBC HOLDINGS PLC
13F
Company
0.3%
148,812
$10,427,059 30 Sep 2023
13F
IRIDIAN ASSET MANAGEMENT LLC/CT
13F
Company
0.3%
145,033
$10,136,356 30 Sep 2023
13F
Tri Locum Partners LP
13F
Company
0.29%
142,510
$9,960,024 30 Sep 2023
13F
US BANCORP \DE\
13F
Company
0.28%
138,771
$9,698,705 30 Sep 2023
13F
FARALLON CAPITAL MANAGEMENT LLC
13F
Company
0.26%
125,653
$8,781,888 30 Sep 2023
13F
JANE STREET GROUP, LLC
13F
Company
0.26%
125,581
$8,776,856 30 Sep 2023
13F
PUTNAM INVESTMENTS LLC
13F
Company
0.25%
120,266
$8,405,390 30 Sep 2023
13F
Ally Bridge Group (NY) LLC
13F
Company
0.23%
110,600
$7,729,834 30 Sep 2023
13F
Ghost Tree Capital, LLC
13F
Company
0.22%
110,000
$7,687,900 30 Sep 2023
13F
Cannell & Co.
13F
Company
0.21%
104,190
$7,281,839 30 Sep 2023
13F
Allspring Global Investments Holdings, LLC
13F
Company
0.21%
103,721
$7,249,060 30 Sep 2023
13F

Institutional Holders of Axsome Therapeutics, Inc. - Common Stock (AXSM) as of Q4 2023

As of 31 Dec 2023, Axsome Therapeutics, Inc. - Common Stock (AXSM) was held by 242 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 38,597,370 shares. The largest 10 holders included RTW INVESTMENTS, LP, VANGUARD GROUP INC, BlackRock Inc., Fairmount Funds Management LLC, BVF INC/IL, CITADEL ADVISORS LLC, PERCEPTIVE ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P., Deep Track Capital, LP, and STATE STREET CORP. This page lists 243 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders
224
Q4 2023 holders
242
Holder diff
18
Investor Q3 2023 Shares Q4 2023 Shares Share Diff Share Chg % Q3 2023 Value $ Q4 2023 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .